Kristopher R Bosse Advances in Neuroblastoma Research Congress 2016

Kristopher R Bosse

Dr. Kristopher Bosse is a hematology/oncology fellow at the Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn). Dr. Bosse graduated summa cum laude with honors from Bowdoin College and he completed his medical degree and residency at Penn and CHOP. Dr. Bosse is a physician-scientist focused on the pediatric cancer neuroblastoma and works in the laboratory of Dr. John Maris, a world-renowned leader in neuroblastoma translational science. After starting his research career focused in the physical sciences, Dr. Bosse was awarded a prestigious Howard Hughes Medical Institute Training Award during medical school to investigate the functional mechanisms underlying several neuroblastoma predisposition loci discovered via a genome-wide association study approach. Dr. Bosse is currently part of a large collaborative effort funded by a Stand Up to Cancer-St. Baldrick’s Foundation grant to bring the fields of genomics and immunology together to combat childhood cancers. Specifically, Dr. Bosse is using an integrated genomic and functional approach to identify and validate novel cell surface molecules for immunotherapeutic targeting in high-risk neuroblastoma. During his brief medical and research career, Dr. Bosse has published 14 peer reviewed manuscripts and has received several research fellowships to support his research efforts. He has also been awarded multiple awards, including a recent AACR/Aflac Scholar-in-Training Travel Award, 2 CHOP Research Day Poster Prizes, a Merck Index Award, and a Philip W. Meserve Prize in Chemistry. Dr. Bosse ultimately aims to develop a translational research career with the goal of bringing novel laboratory discoveries in the most aggressive pediatric malignancies to the clinic to make impactful improvements in clinical care.